Preparation of dual-targeting ERK1 and ERK5 inhibitor and anti-tumor application of dual-targeting ERK1 and ERK5 inhibitors
An anti-tumor drug and application technology, applied in the field of anti-tumor pharmacy, can solve problems such as the lack of development of dual-target ERK1 and ERK5 inhibitors, and achieve the effect of inhibiting growth and obvious inhibitory effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0050] Example 1 Synthesis of Preferred Compounds.
[0051] Preferred compounds are synthesized using the following reaction formula:
[0052]
[0053] i ethanol, heated to reflux; ii DIEA, acid chloride, room temperature; iii methanol saturated hydrochloric acid solution, 0°C; iv benzyl chloride, K2CO3, DMF, 80°C; v isothiocyanate, DIEA, dichloromethane, room temperature.
[0054] 1. General synthesis of intermediates 1-3
[0055]In anhydrous ethanol (200 mL) solution was added tert-butyl 4-opopiperidine-1-carboxylate (30.0 mmol), 2-cyanoacetamide (30.0 mmol) and sulfur (30.0 mmol), morpholine (30.0 mmol) mmol). The mixture was stirred and refluxed for 8 hours, the mixture was cooled to room temperature, filtered, washed three times with 30 ml of ethanol, and the filtrate was suspended and concentrated to dryness. The crude product was diluted with 95% ethanol (30 mL) and filtered to give Intermediate 1 as a white solid.
[0056] Intermediate 1 (10 mmol) and DIEA (20 m...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap